Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In Preclinical Model of Ovarian Cancer, the SGK1 Inhibitor SI113 Counteracts the Development of Paclitaxel Resistance and Restores Drug Sensitivity.
D'Antona L, Dattilo V, Catalogna G, Scumaci D, Fiumara CV, Musumeci F, Perrotti G, Schenone S, Tallerico R, Spoleti CB, Costa N, Iuliano R, Cuda G, Amato R, Perrotti N. D'Antona L, et al. Among authors: schenone s. Transl Oncol. 2019 Aug;12(8):1045-1055. doi: 10.1016/j.tranon.2019.05.008. Epub 2019 Jun 1. Transl Oncol. 2019. PMID: 31163384 Free PMC article.
A1 receptors ligands: past, present and future trends.
Schenone S, Brullo C, Musumeci F, Bruno O, Botta M. Schenone S, et al. Curr Top Med Chem. 2010;10(9):878-901. doi: 10.2174/156802610791268729. Curr Top Med Chem. 2010. PMID: 20370661 Review.
ATP-competitive inhibitors of mTOR: an update.
Schenone S, Brullo C, Musumeci F, Radi M, Botta M. Schenone S, et al. Curr Med Chem. 2011;18(20):2995-3014. doi: 10.2174/092986711796391651. Curr Med Chem. 2011. PMID: 21651476 Review.
An update on dual Src/Abl inhibitors.
Musumeci F, Schenone S, Brullo C, Botta M. Musumeci F, et al. Among authors: schenone s. Future Med Chem. 2012 Apr;4(6):799-822. doi: 10.4155/fmc.12.29. Future Med Chem. 2012. PMID: 22530642 Review.
In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold.
Ortuso F, Amato R, Artese A, D'antona L, Costa G, Talarico C, Gigliotti F, Bianco C, Trapasso F, Schenone S, Musumeci F, Botta L, Perrotti N, Alcaro S. Ortuso F, et al. Among authors: schenone s. J Chem Inf Model. 2014 Jul 28;54(7):1828-32. doi: 10.1021/ci500235f. Epub 2014 Jun 13. J Chem Inf Model. 2014. PMID: 24896223
213 results